Vorinostat Terminated Phase 1 Trials for Transitional Cell Carcinoma / Lung Cancer Non-Small Cell Cancer (NSCLC) / Non-small Cell Lung, Prostate, Bladder/Urothelial Cancers / Bladder Cancers / Prostate Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00565227Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.
NCT00702572Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung Cancer